» Articles » PMID: 21914515

Time Trade-off Derived EQ-5D Weights for Australia

Overview
Journal Value Health
Publisher Elsevier
Date 2011 Sep 15
PMID 21914515
Citations 89
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cost-utility analyses (CUAs) are increasingly common in Australia. The EuroQol five-dimensional (EQ-5D) questionnaire is one of the most widely used generic preference-based instruments for measuring health-related quality of life for the estimation of quality-adjusted life years within a CUA. There is evidence that valuations of health states vary across countries, but Australian weights have not previously been developed.

Methods: Conventionally, weights are derived by applying the time trade-off elicitation method to a subset of the EQ-5D health states. Using a larger set of directly valued health states than in previous studies, time trade-off valuations were collected from a representative sample of the Australian general population (n = 417). A range of models were estimated and compared as a basis for generating an Australian algorithm.

Results: The Australia-specific EQ-5D values generated were similar to those previously produced for a range of other countries, but the number of directly valued states allowed inclusion of more interaction effects, which increased the divergence between Australia's algorithm and other algorithms in the literature.

Conclusion: This new algorithm will enable the Australian community values to be reflected in future economic evaluations.

Citing Articles

Outcomes from the Victorian Healthy Homes Program: a randomised control trial of home energy upgrades.

Page K, Hossain L, Liu D, Kim Y, Wilmot K, Kenny P BMJ Open. 2025; 15(2):e082340.

PMID: 40010814 PMC: 11865758. DOI: 10.1136/bmjopen-2023-082340.


Implementing Guidelines for hypothermia prevention with Local adaptation to keep periOperative patients Warm (GLOW): protocol of a stepped-wedge cluster randomised hybrid type II effectiveness-implementation study.

Munday J, Duff J, Wood F, Sturgess D, Keogh S, Ralph N BMJ Open. 2025; 15(2):e091577.

PMID: 39938961 PMC: 11822429. DOI: 10.1136/bmjopen-2024-091577.


How do children understand and respond to the EQ-5D-Y-3L? A mixed methods study in a community-based sample of 6-12-year-olds.

Khanna D, Lay K, Khadka J, Mpundu-Kaambwa C, Ratcliffe J Health Qual Life Outcomes. 2024; 22(1):105.

PMID: 39633400 PMC: 11619400. DOI: 10.1186/s12955-024-02320-4.


Patient Reported Outcome Measures in cancer care: a hybrid effectiveness-Implementation trial to optimise Symptom control and health service Experience (PROMISE)-protocol for a randomised controlled trial of electronic self-reporting of symptoms....

Webb P, Brown A, Brown B, Collins L, Crawford Williams F, Doupain K BMJ Open. 2024; 14(11):e090836.

PMID: 39566946 PMC: 11580250. DOI: 10.1136/bmjopen-2024-090836.


Cancer-specific utility: clinical validation of the EORTC QLU-C10D in patients with glioblastoma.

Seyringer S, Pilz M, Bottomley A, King M, Norman R, Gamper E Eur J Health Econ. 2024; .

PMID: 39565523 DOI: 10.1007/s10198-024-01729-4.